Serum Cystatin C and Emphysema: Results from the National Health and Nutrition Examination Survey (NHANES)

[1]  R. Sandhaus,et al.  Experimental emphysema induced with purified human neutrophil elastase: tissue localization of the instilled protease. , 2015, The American review of respiratory disease.

[2]  Ying Yang,et al.  Elevated serum cystatin C is an independent predictor of cardiovascular events in people with relatively normal renal function. , 2012, Journal of nephrology.

[3]  R. Ekart,et al.  Simple Cystatin C Formula Compared to Sophisticated CKD‐EPI Formulas for Estimation of Glomerular Filtration Rate in the Elderly , 2011, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[4]  M. Horwitz,et al.  Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases , 2010, Pharmacological Reviews.

[5]  K. Clément,et al.  Cathepsins and cystatin C in atherosclerosis and obesity. , 2010, Biochimie.

[6]  M. Bastos,et al.  Monitoring renal function: measured and estimated glomerular filtration rates - a review. , 2010, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[7]  M. Hendrix,et al.  Reevaluating Cathepsin D as a biomarker for breast cancer: Serum activity levels versus histopathology , 2010, Cancer biology & therapy.

[8]  Aaliya Shah,et al.  Cystatins in Health and Diseases , 2008, International Journal of Peptide Research and Therapeutics.

[9]  C. Owen.  Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease , 2008, International journal of chronic obstructive pulmonary disease.

[10]  G. Lungarella,et al.  The dual role of neutrophil elastase in lung destruction and repair. , 2008, The international journal of biochemistry & cell biology.

[11]  F. Stanzel,et al.  Cathepsin H and napsin A are active in the alveoli and increased in alveolar proteinosis , 2008, European Respiratory Journal.

[12]  R. Abboud,et al.  Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[13]  A. Köttgen,et al.  Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III). , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  J. Coresh,et al.  Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  J. Coresh,et al.  Prevalence of chronic kidney disease in the United States. , 2007, JAMA.

[16]  J. Kos,et al.  Cystatins in non-small cell lung cancer: tissue levels, localization and relation to prognosis. , 2006, Oncology reports.

[17]  G. Laurent,et al.  Neutrophil elastase: mediator of extracellular matrix destruction and accumulation. , 2006, Proceedings of the American Thoracic Society.

[18]  R. Pierce,et al.  Imbalance between cysteine proteases and inhibitors in a baboon model of bronchopulmonary dysplasia. , 2006, American journal of respiratory and critical care medicine.

[19]  D. Siscovick,et al.  Cystatin C and the risk of death and cardiovascular events among elderly persons. , 2005, The New England journal of medicine.

[20]  S. Rennard,et al.  Pathogenesis of COPD , 2005, Seminars in respiratory and critical care medicine.

[21]  G. Eknoyan,et al.  National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification , 2003, Annals of Internal Medicine.

[22]  E. Spiess,et al.  Cystatins C, E/M and F in Human Pleural Fluids of Patients with Neoplastic and Inflammatory Lung Disorders , 2003, Biological chemistry.

[23]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  V. Dharnidharka,et al.  Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  J. Kos,et al.  Cysteine Proteinases and Their Inhibitors in Extracellular Fluids: Markers for Diagnosis and Prognosis in Cancer , 2000, The International journal of biological markers.

[26]  C. Owen,et al.  The cell biology of leukocyte‐mediated proteolysis , 1999, Journal of leukocyte biology.

[27]  T. Betsuyaku,et al.  Cysteine proteinases and cystatin C in bronchoalveolar lavage fluid from subjects with subclinical emphysema. , 1998, The European respiratory journal.

[28]  J. Kos,et al.  Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review). , 1998, Oncology reports.

[29]  C. O'connor,et al.  Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. , 1997, Thorax.

[30]  E. Veerman,et al.  Cystatins in health and disease. , 1996, Biological chemistry Hoppe-Seyler.

[31]  M. Cosio,et al.  Alveolar inflammation and its relation to emphysema in smokers. , 1995, American journal of respiratory and critical care medicine.

[32]  P. Nilsson-ehle,et al.  Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. , 1994, Clinical chemistry.

[33]  M. Padilla,et al.  Induction of emphysema in hamsters by intratracheal instillation of cathepsin B. , 1992, The American review of respiratory disease.

[34]  A. Warfel,et al.  Cystatin C and Cathepsin B Production by Alveolar Macrophages From Smokers and Nonsmokers , 1991, Journal of leukocyte biology.

[35]  M. Abrahamson,et al.  Levels of neutrophil elastase and cathepsin b activities and cystatins in human sputum relationship to inflammation , 1990 .

[36]  Bonnie F. Sloane,et al.  Role for cathepsin B and cystatins in tumor growth and progression. , 1990, Biological chemistry Hoppe-Seyler.

[37]  J. Reilly,et al.  Identification of cystatin C, a cysteine proteinase inhibitor, as a major secretory product of human alveolar macrophages in vitro. , 1990, The American review of respiratory disease.

[38]  H. Chapman,et al.  Comparison of live human neutrophil and alveolar macrophage elastolytic activity in vitro. Relative resistance of macrophage elastolytic activity to serum and alveolar proteinase inhibitors. , 1984, The Journal of clinical investigation.

[39]  T. O'riordan,et al.  Potential role of inhibitors of neutrophil elastase in treating diseases of the airway. , 2004, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[40]  H. Nielsen,et al.  Cathepsin B/Cystatin C Complex Levels in Sera from Patients with Lung and Colorectal Cancer , 2001, Biological chemistry.

[41]  V. I. Kaledin,et al.  Cysteine proteinase inhibitor level in tumor and normal tissues in control and cured mice. , 2000, Drugs under experimental and clinical research.

[42]  J. Procházka,et al.  Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer. , 1998, Neoplasma.

[43]  V. Turk,et al.  Cathepsin B and cysteine proteinase inhibitors in bronchoalveolar lavage fluid of lung cancer patients. , 1993, Cancer detection and prevention.